Strain Differences Separate Helpful and Harmful Elements of the Human Microbiome
|
By LabMedica International staff writers Posted on 12 Mar 2013 |
A recent microbiome study demonstrated the importance of evaluating bacteria at the strain rather than the genus or species level in order to understand their contribution to human health or disease.
Investigators at the University of California, Los Angeles (USA) and collaborators at Washington University (St. Louis, MO, USA) and the Los Angeles Biomedical Research Institute (CA, USA) selected the skin disorder acne as a model to explore the relationship between the causative organism Propionibacterium acnes and the human immune system, which generates the inflammatory response that causes the characteristic pimples, redness, and blotchy skin.
The investigators compared the skin microbiome at the strain level and genome level of P. acnes between 49 acne patients and 52 healthy individuals by sampling the sebaceous units on their noses. More than 1,000 strains of the bacteria were cultured from the isolates, and the genomes of 66 of the P. acnes strains were sequenced.
Metagenomic analysis published in the February 28, 2013, online edition of the Journal of Investigative Dermatology demonstrated that although the relative abundances of P. acnes were similar, the strain population structures were significantly different in the two cohorts. Certain strains were highly associated with acne, and other strains were enriched in healthy skin.
By sequencing 66 previously unreported P. acnes strains and comparing 71 P. acnes genomes, the investigators identified potential genetic determinants of various P. acnes strains in association with acne or health. The analysis suggested that acquired DNA sequences and bacterial immune elements may have roles in determining virulence properties of P. acnes strains, and some could be future targets for therapeutic interventions. Furthermore, the results underscored the importance of strain-level analysis of the human microbiome to define the role of the microbial flora in health and disease.
"We learned that not all acne bacteria trigger pimples—one strain may actually help keep skin healthy," said senior author Dr. Huiying Li, assistant professor of molecular and medical pharmacology at the University of California, Los Angeles. "We hope to apply our findings to develop new strategies that stop blemishes before they start, and enable dermatologists to customize treatment to each patient's unique cocktail of skin bacteria."
"We were extremely excited to uncover a third strain of P. acnes that is common in healthy skin yet rarely found when acne is present," said Dr. Li. "We suspect that this strain contains a natural defense mechanism that enables it to recognize attackers and destroy them before they infect the bacterial cell. This P. acnes strain may protect the skin, much like yogurt's live bacteria help defend the gut from harmful bugs. Our next step will be to investigate whether a probiotic cream can block bad bacteria from invading the skin and prevent pimples before they start."
Related Links:
University of California, Los Angeles
Washington University
Los Angeles Biomedical Research Institute
Investigators at the University of California, Los Angeles (USA) and collaborators at Washington University (St. Louis, MO, USA) and the Los Angeles Biomedical Research Institute (CA, USA) selected the skin disorder acne as a model to explore the relationship between the causative organism Propionibacterium acnes and the human immune system, which generates the inflammatory response that causes the characteristic pimples, redness, and blotchy skin.
The investigators compared the skin microbiome at the strain level and genome level of P. acnes between 49 acne patients and 52 healthy individuals by sampling the sebaceous units on their noses. More than 1,000 strains of the bacteria were cultured from the isolates, and the genomes of 66 of the P. acnes strains were sequenced.
Metagenomic analysis published in the February 28, 2013, online edition of the Journal of Investigative Dermatology demonstrated that although the relative abundances of P. acnes were similar, the strain population structures were significantly different in the two cohorts. Certain strains were highly associated with acne, and other strains were enriched in healthy skin.
By sequencing 66 previously unreported P. acnes strains and comparing 71 P. acnes genomes, the investigators identified potential genetic determinants of various P. acnes strains in association with acne or health. The analysis suggested that acquired DNA sequences and bacterial immune elements may have roles in determining virulence properties of P. acnes strains, and some could be future targets for therapeutic interventions. Furthermore, the results underscored the importance of strain-level analysis of the human microbiome to define the role of the microbial flora in health and disease.
"We learned that not all acne bacteria trigger pimples—one strain may actually help keep skin healthy," said senior author Dr. Huiying Li, assistant professor of molecular and medical pharmacology at the University of California, Los Angeles. "We hope to apply our findings to develop new strategies that stop blemishes before they start, and enable dermatologists to customize treatment to each patient's unique cocktail of skin bacteria."
"We were extremely excited to uncover a third strain of P. acnes that is common in healthy skin yet rarely found when acne is present," said Dr. Li. "We suspect that this strain contains a natural defense mechanism that enables it to recognize attackers and destroy them before they infect the bacterial cell. This P. acnes strain may protect the skin, much like yogurt's live bacteria help defend the gut from harmful bugs. Our next step will be to investigate whether a probiotic cream can block bad bacteria from invading the skin and prevent pimples before they start."
Related Links:
University of California, Los Angeles
Washington University
Los Angeles Biomedical Research Institute
Latest BioResearch News
- Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns
- Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma
- New Method Simplifies Preparation of Tumor Genomic DNA Libraries
- New Tool Developed for Diagnosis of Chronic HBV Infection
- Panel of Genetic Loci Accurately Predicts Risk of Developing Gout
- Disrupted TGFB Signaling Linked to Increased Cancer-Related Bacteria
- Gene Fusion Protein Proposed as Prostate Cancer Biomarker
- NIV Test to Diagnose and Monitor Vascular Complications in Diabetes
- Semen Exosome MicroRNA Proves Biomarker for Prostate Cancer
- Genetic Loci Link Plasma Lipid Levels to CVD Risk
- Newly Identified Gene Network Aids in Early Diagnosis of Autism Spectrum Disorder
- Link Confirmed between Living in Poverty and Developing Diseases
- Genomic Study Identifies Kidney Disease Loci in Type I Diabetes Patients
- Liquid Biopsy More Effective for Analyzing Tumor Drug Resistance Mutations
- New Liquid Biopsy Assay Reveals Host-Pathogen Interactions
- Method Developed for Enriching Trophoblast Population in Samples
Channels
Clinical Chemistry
view channel
Online Tool Detects Drug Exposure Directly from Patient Samples
Doctors often rely on patient interviews and medical records to determine what medications a person has taken, but this information is frequently incomplete. People may forget drugs they used, take over-the-counter... Read more
Chemical Imaging Probe Could Track and Treat Prostate Cancer
Prostate cancer remains a leading cause of illness and death among men, with many patients eventually developing resistance to standard hormone-blocking therapies. These drugs often lose effectiveness... Read moreMolecular Diagnostics
view channel
New 15-Minute Hepatitis C Test Paves Way for Same-Day Treatment
Chronic hepatitis C infection affects an estimated 50 million people worldwide and causes around 242,000 deaths each year, largely due to cirrhosis and liver cancer. Although the infection is curable with... Read more
Ovarian Cancer Assay Outperforms Traditional Tests in Early Disease Detection
Globally, ovarian cancer is one of the deadliest cancers affecting women. Traditionally, early diagnosis of ovarian cancer has been challenging. Many ovarian cancers are diagnosed only after they have... Read moreHematology
view channel
MRD Tests Could Predict Survival in Leukemia Patients
Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more
Platelet Activity Blood Test in Middle Age Could Identify Early Alzheimer’s Risk
Early detection of Alzheimer’s disease remains one of the biggest unmet needs in neurology, particularly because the biological changes underlying the disorder begin decades before memory symptoms appear.... Read more
Microvesicles Measurement Could Detect Vascular Injury in Sickle Cell Disease Patients
Assessing disease severity in sickle cell disease (SCD) remains challenging, especially when trying to predict hemolysis, vascular injury, and risk of complications such as vaso-occlusive crises.... Read more
ADLM’s New Coagulation Testing Guidance to Improve Care for Patients on Blood Thinners
Direct oral anticoagulants (DOACs) are one of the most common types of blood thinners. Patients take them to prevent a host of complications that could arise from blood clotting, including stroke, deep... Read moreImmunology
view channel
Routine Blood Test Can Predict Who Benefits Most from CAR T-Cell Therapy
CAR T-cell therapy has transformed treatment for patients with relapsed or treatment-resistant non-Hodgkin lymphoma, but many patients eventually relapse despite an initial response. Clinicians currently... Read more
New Test Distinguishes Vaccine-Induced False Positives from Active HIV Infection
Since HIV was identified in 1983, more than 91 million people have contracted the virus, and over 44 million have died from related causes. Today, nearly 40 million individuals worldwide live with HIV-1,... Read more
Gene Signature Test Predicts Response to Key Breast Cancer Treatment
DK4/6 inhibitors paired with hormone therapy have become a cornerstone treatment for advanced HR+/HER2– breast cancer, slowing tumor growth by blocking key proteins that drive cell division.... Read more
Chip Captures Cancer Cells from Blood to Help Select Right Breast Cancer Treatment
Ductal carcinoma in situ (DCIS) accounts for about a quarter of all breast cancer cases and generally carries a good prognosis. This non-invasive form of the disease may or may not become life-threatening.... Read moreMicrobiology
view channel
Blood-Based Diagnostic Method Could Identify Pediatric LRTIs
Lower-respiratory tract infections (LRTIs) are a leading cause of illness and death worldwide, and pneumonia is the leading infectious cause of death in children under five, claiming the lives of over... Read more
Rapid Diagnostic Test Matches Gold Standard for Sepsis Detection
Sepsis kills 11 million people worldwide every year and generates massive healthcare costs. In the USA and Europe alone, sepsis accounts for USD 100 billion in annual hospitalization expenses.... Read moreRapid POC Tuberculosis Test Provides Results Within 15 Minutes
Tuberculosis remains one of the world’s deadliest infectious diseases, and reducing new cases depends on identifying individuals with latent infection before it progresses. Current diagnostic tools often... Read more
Rapid Assay Identifies Bloodstream Infection Pathogens Directly from Patient Samples
Bloodstream infections in sepsis progress quickly and demand rapid, precise diagnosis. Current blood-culture methods often take one to five days to identify the pathogen, leaving clinicians to treat blindly... Read morePathology
view channel
Rapid Low-Cost Tests Can Prevent Child Deaths from Contaminated Medicinal Syrups
Medicinal syrups contaminated with toxic chemicals have caused the deaths of hundreds of children worldwide, exposing a critical gap in how these products are tested before reaching patients.... Read more
Tumor Signals in Saliva and Blood Enable Non-Invasive Monitoring of Head and Neck Cancer
Head and neck cancers are among the most aggressive malignancies worldwide, with nearly 900,000 new cases diagnosed each year. Monitoring these cancers for recurrence or relapse typically relies on tissue... Read more
Common Health Issues Can Influence New Blood Tests for Alzheimer’s Disease
Blood-based tests for Alzheimer’s disease are transforming diagnosis by offering a simpler alternative to spinal taps and brain imaging. However, many people evaluated at memory clinics also live with... Read more
Blood Test Formula Identifies Chronic Liver Disease Patients with Higher Cancer Risk
Chronic liver disease affects millions worldwide and can progress silently to hepatocellular carcinoma (HCC), one of the deadliest cancers globally. While surveillance guidelines exist for patients with... Read moreTechnology
view channel
Machine Learning Models Diagnose ALS Earlier Through Blood Biomarkers
Amyotrophic lateral sclerosis (ALS) is a rapidly progressive neurodegenerative disease that is notoriously difficult to diagnose in its early stages. Early symptoms often overlap with other neurological... Read more
Artificial Intelligence Model Could Accelerate Rare Disease Diagnosis
Identifying which genetic variants actually cause disease remains one of the biggest challenges in genomic medicine. Each person carries tens of thousands of DNA changes, yet only a few meaningfully alter... Read moreIndustry
view channel
Abbott Acquires Cancer-Screening Company Exact Sciences
Abbott (Abbott Park, IL, USA) has entered into a definitive agreement to acquire Exact Sciences (Madison, WI, USA), enabling it to enter and lead in fast-growing cancer diagnostics segments.... Read more






 Analyzer.jpg)

